Peter Barrett

Insider Reports History

Entity
Individual
Location
C/O Alnylam Pharmaceuticals, Inc., 300 Third Street, Cambridge, MA
Signature
/s/ John L. Healy (POA on file) for Peter Barrett
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Barrett:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REVVITY, INC. Director Common Stock 23.6K $2.44M $103.49 May 1, 2024 Direct
SYNLOGIC, INC. Director Stock Option (right to buy) 24.9K Jan 2, 2024 Direct
Larimar Therapeutics, Inc. Director Stock Option (Right to Buy) 8.3K May 10, 2022 Direct

Insider Reports Filed by Peter Barrett

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVTY REVVITY, INC. May 1, 2024 2 $0 4 May 2, 2024 Director
SYBX SYNLOGIC, INC. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
SYBX SYNLOGIC, INC. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
RVTY REVVITY, INC. May 15, 2023 2 $0 4 May 17, 2023 Director
SYBX SYNLOGIC, INC. Jan 3, 2023 1 $0 4 Jan 4, 2023 Director
SYBX SYNLOGIC, INC. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
LRMR Larimar Therapeutics, Inc. May 10, 2022 1 $0 4 May 12, 2022 Director
RVTY PERKINELMER INC May 6, 2022 2 $0 4 May 9, 2022 Director
SYBX SYNLOGIC, INC. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
RVTY PERKINELMER INC Jul 30, 2021 1 $0 4 Aug 2, 2021 Director
SYBX SYNLOGIC, INC. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
LRMR Larimar Therapeutics, Inc. May 12, 2021 1 $0 4 May 17, 2021 Director
RVTY PERKINELMER INC May 7, 2021 2 $0 4 May 10, 2021 Director